At 10 days after infection, we observed significant augmentation of stem-like CD8+ T cell numbers and a slight reduction of the more-differentiated TIM3+TCF1– population in rapamycin-treated mice (Figure 1, D and E), accompanied by increased viral load (Supplemental Figure 2). The gene discussed is CD8A; the disease is infection.